This article for the Atlantic outlines Biden’s lukewarm stance on legalization and more. Current legalization measures harness bipartisan support, for reasons ranging from increased tax revenue for cities, to criminal justice reform. Biden, however, "Won’t inhale." He’s looking for more concrete research, he says.
This story was first reported on Marijuana Moment.
The role of medicinal cannabis in PTSD treatment can not be downplayed. Let’s remember all of the intersections of experiences & identity that medicinal patients and recreational users represent. This article is a great reminder, by Bruce Kennedy for Politico.
“In the last 18 months though, [MedMen has] been among the hardest hit by a trend of market corrections, culminating in Interim CEO Ryan Lissack telling CNN that, “While vertical integration has been a big focus in the industry, our growing belief is that cannabis is evolving like every other consumer vertical: with a fragmented value chain and specialists at each layer.”
Brett Puffenbarger for Ganjapreneur.com
& The senate has “no intention to consider the bill.”
New Dawn Risk has published a report, “Understanding and Opening up the US cannabis insurance market.”
In San Francisco, total sales have more than doubled in the past five years but, on average, sales at individual stores and dispensaries are falling. According to the controller’s report, individual outlet sales dropped 45% — from $6.3 million to $3.4 million in 2018 — in part because 44 new retailers and delivery services entered the market, creating more competition along with an Illicit market that is still thriving. A 2019 audit, conducted by the United Cannabis Business Association (UCBA) a state industry trade organization, found approximately 2,835 unlicensed dispensaries and delivery services operating in California, compared to 873 licensed sellers.